翻訳と辞書 |
Lampalizumab : ウィキペディア英語版 | Lampalizumab
Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody designed for the treatment of geographic atrophy secondary to age-related macular degeneration. It binds to CFD.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Lampalizumab ), ''American Medical Association''.〕 Enrollment in Phase 3 clinical trials has been initiated.〔(Roche starts Phase III trials of lampalizumab ), PharmaTimes〕 Phase 3 trials are usually conducted in order to establish the effectiveness of a drug, and compare the results to known alternative treatments.〔(), "NIH - US National Library of Medicine"〕 == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Lampalizumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|